Ribosomally synthesized and post-translationally modified peptide natural products: Overview and recommendations for a universal nomenclature

Paul G. Arnison, Mervyn J. Bibb, Gabriele Bierbaum, Albert A. Bowers, Tim S. Bugni, Grzegorz Bulaj, Julio A. Camarero, Dominic J. Campopiano, Gregory L. Challis, Jon Clardy, Paul D. Cotter, David J. Craik, Michael Dawson, Elke Dittmann, Stefano Donadio, Pieter C. Dorrestein, Karl Dieter Entian, Michael A. Fischbach, John S. Garavelli, Ulf GöranssonChristian W. Gruber, Daniel H. Haft, Thomas K. Hemscheidt, Christian Hertweck, Colin Hill, Alexander R. Horswill, Marcel Jaspars, Wendy L. Kelly, Judith P. Klinman, Oscar P. Kuipers, A. James Link, Wen Liu, Mohamed A. Marahiel, Douglas A. Mitchell, Gert N. Moll, Bradley S. Moore, Rolf Müller, Satish K. Nair, Ingolf F. Nes, Gillian E. Norris, Baldomero M. Olivera, Hiroyasu Onaka, Mark L. Patchett, Joern Piel, Martin J.T. Reaney, Sylvie Rebuffat, R. Paul Ross, Hans Georg Sahl, Eric W. Schmidt, Michael E. Selsted, Konstantin Severinov, Ben Shen, Kaarina Sivonen, Leif Smith, Torsten Stein, Roderich D. Süssmuth, John R. Tagg, Gong Li Tang, Andrew W. Truman, John C. Vederas, Christopher T. Walsh, Jonathan D. Walton, Silke C. Wenzel, Joanne M. Willey, Wilfred A. Van Der Donk

Research output: Contribution to journalReview articlepeer-review

1020 Scopus citations

Fingerprint

Dive into the research topics of 'Ribosomally synthesized and post-translationally modified peptide natural products: Overview and recommendations for a universal nomenclature'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds